References
- Abdus-Salam AA, Ogunnorin BO, Adenipekun AA, Olabumuyi A, Olabumuyi O. Percentage body fat in breast cancer patients at The University College Hospital, Ibadan: a case-control study. Niger J Med. 2019;28(1):237–47.
- Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420(6917):860–7. doi:https://doi.org/10.1038/nature01322
- Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature. 2008;454(7203):436–44. doi:https://doi.org/10.1038/nature07205
- Gray S, Axelsson B. The prevalence of deranged C-reactive protein and albumin in patients with incurable cancer approaching death. PLoS One. 2018;13(3):e0193693. doi:https://doi.org/10.1371/journal.pone.0193693
- Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100(1):57–70. doi:https://doi.org/10.1016/S0092-8674(00)81683-9
- Matthys P, Billiau A. Cytokines and Cachexia. Nutrition. 1997;13(9):763–70. doi:https://doi.org/10.1016/S0899-9007(97)00185-8
- Laviano A, Meguid MM, Preziosa I, Fanelli FR. Oxidative stress and wasting in cancer. Curr Opin Clin Nutr Metab Care. 2007;10(4):449–56. doi:https://doi.org/10.1097/MCO.0b013e328122db94
- Petekkaya I, Unlu O, Roach EC, Gecmez G, Okoh A, Babacan T, Sarici F, Keskin O, Arslan C, Petekkaya E. Prognostic role of inflammatory biomarkers in metastatic breast cancer. J BUON. 2017;22(3):614–22.
- Miura T, Matsumoto Y, Hama T, Amano K, Tei Y, Kikuchi A, Suga A, Hisanaga T, Ishihara T, Abe M, et al. Glasgow prognostic score predicts prognosis for cancer patients in palliative settings: a subanalysis of the Japan–prognostic assessment tools validation (J-ProVal) study. Support Care Cancer. 2015;23(11):3149–56. doi:https://doi.org/10.1007/s00520-015-2693-x
- Gomes de Lima KV, Maio R. Nutritional status, systemic inflammation and prognosis of patients with gastrointestinal cancer. Nutr Hosp. 2012;27(3):707–14.
- Opanga Y, Kaduka L, Bukania Z, Mutisya R, Korir A, Thuita V, Mwangi M, Muniu E, Mbakaya C. Nutritional status of cancer outpatients using patient-generated subjective global assessment in two cancer treatment centers, Nairobi, Kenya. BMC Nutr. 2017;3(1):63. doi:https://doi.org/10.1186/s40795-017-0181-z
- Brinksma A, Huizinga G, Sulkers E, Kamps W, Roodbol P, Tissing W. Malnutrition in childhood cancer patients: a review on its prevalence and possible causes. Crit Rev Oncol Hematol. 2012;83(2):249–75. doi:https://doi.org/10.1016/j.critrevonc.2011.12.003
- McMillan DC. An inflammation-based prognostic score and its role in the nutrition-based management of patients with cancer. Proc Nutr Soc. 2008;67(3):257–62. doi:https://doi.org/10.1017/S0029665108007131
- Parasa K, Avvaru K. Assessment of nutritional status of cancer patients using scored PG-SGA tool. IOSR. 2016;15(08):37–861. doi:https://doi.org/10.9790/0853-1508013740
- Nouh F, Omar M, Younis M, Younis M, Mohamed R, Gaith R, Reyad W. Nutritional status of female breast cancer patients in Benghazi City of Libya. JCTI. 2017;6(3):1–2187. doi:https://doi.org/10.9734/JCTI/2017/38345
- [accessed 2018 Jan 12]. https://nutritioncareincanada.ca/resources-and-tools/hospital-care-inpac/assessment-sga.
- World Health Organization. Obesity: preventing and managing the global epidemic. Geneva: WHO; 1997.
- McMillan DC. Systemic inflammation, nutritional status and survival in patients with cancer. Curr Opin Clin Nutr Metab Care. 2009;12(3):223–6. doi:https://doi.org/10.1097/MCO.0b013e32832a7902
- Alberici Pastore C, Paiva Orlandi S, González MC. Association between an inflammatory-nutritional index and nutritional status in cancer patients. Nutr Hosp. 2013;28(1):188–93. doi:https://doi.org/10.3305/nh.2013.28.1.6167
- Balkwill FR. The chemokine system and cancer. J Pathol. 2012;226(2):148–57. doi:https://doi.org/10.1002/path.3029
- Guthrie GJ, Roxburgh CS, Horgan PG, McMillan DC. Does interleukin-6 link explain the link between tumour necrosis, local and systemic inflammatory responses and outcome in patients with colorectal cancer? Cancer Treat Rev. 2013;39(1):89–96. doi:https://doi.org/10.1016/j.ctrv.2012.07.003
- Hoesel B, Schmid JA. The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer. 2013;12:86. doi:https://doi.org/10.1186/1476-4598-12-86
- Elinav E, Nowarski R, Thaiss CA, Hu B, Jin C, Flavell RA. Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms. Nat Rev Cancer. 2013;13(11):759–71. doi:https://doi.org/10.1038/nrc3611
- Silva G. A d, Wiegert EVM, Calixto-Lima L, Oliveira LC. Clinical utility of the modified Glasgow Prognostic Score to classify cachexia in patients with advanced cancer in palliative care. Clin Nutr. 2020;39(5):1587–92. doi:https://doi.org/10.1016/j.clnu.2019.07.002
- Walsh D, Mahmoud F, Barna B. Assessment of nutritional status and prognosis in advanced cancer: interleukin-6, C-reactive protein, and the prognostic and inflammatory nutritional index. Support Care Cancer. 2003;11(1):60–2. doi:https://doi.org/10.1007/s00520-002-0390-z
- Makhija S, Baker J. The subjective global assessment: a review of its use in clinical practice. Nutr Clin Pract. 2008;23(4):405–9. doi:https://doi.org/10.1177/0884533608321214
- Bauer J, Capra S, Ferguson M. Use of the scored patient-generated subjective global assessment (PG-SGA) as a nutrition assessment tool in patients with cancer. Eur J Clin Nutr. 2002;56(8):779–85. doi:https://doi.org/10.1038/sj.ejcn.1601412
- Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HO, Engstrom PF, Ezdinli EZ, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med. 1980;69(4):491–7. doi:https://doi.org/10.1016/S0149-2918(05)80001-3
- Vergara N, Montoya JE, Luna HG, Amparo JR, Luna GC. Quality of life and nutritional status among cancer patients on chemotherapy. Oman Med J. 2013;28(4):270–4. doi:https://doi.org/10.5001/omj.2013.75
- Nelson KA, Walsh D. The cancer anorexia-cachexia syndrome: a survey of the prognostic inflammatory and nutritional index (PINI) in advanced disease. J Pain Symptom Manage. 2002;24(4):424–8. doi:https://doi.org/10.1016/S0885-3924(02)00508-0
- Aoyagi T, Terracina KP, Raza A, Matsubara H, Takabe K. Cancer cachexia, mechanism and treatment. World J Gastrointest Oncol. 2015;7(4):17–29. doi:https://doi.org/10.4251/wjgo.v7.i4.17
- Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12(5):489–95. doi:https://doi.org/10.1016/S1470-2045(10)70218-7
- Deans CC, Wigmore SJS. Systemic inflammation, cachexia and prognosis in patients with cancer. Curr Opin Clin Nutr Metab Care. 2005;8(3):265–9. doi:https://doi.org/10.1097/01.mco.0000165004.93707.88
- Allin KH, Nordestgaard BG. Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Crit Rev Clin Lab Sci. 2011;48(4):155–70. doi:https://doi.org/10.3109/10408363.2011.599831
- Park G, Song SY, Ahn J-H, Kim W-L, Lee J-S, Jeong S-Y, Park JW, Choi EK, Choi W, Jung I-H. The pretreatment erythrocyte sedimentation rate predicts survival outcomes after surgery and adjuvant radiotherapy for extremity soft tissue sarcoma. Radiat Oncol. 2019;14(1):116. doi:https://doi.org/10.1186/s13014-019-1331-z
- Tas F, Erturk K. Elevated erythrocyte sedimentation rate is associated with metastatic disease and worse survival in patients with cutaneous malignant melanoma. Mol Clin Onc. 2017;7:1142–6. doi:https://doi.org/10.3892/mco.2017.1440
- Read JA, Choy ST, Beale PJ, Clarke SJ. Evaluation of nutritional and inflammatory status of advanced colorectal cancer patients and its correlation with survival. Nutr Cancer. 2006;55(1):78–85. doi:https://doi.org/10.1207/s15327914nc5501_10
- Watson J, Salisbury C, Banks J, Whiting P, Hamilton W. Predictive value of inflammatory markers for cancer diagnosis in primary care: a prospective cohort study using electronic health records. Br J Cancer. 2019;120(11):1045–51. doi:https://doi.org/10.1038/s41416-019-0458-x
- Chandra RK. Nutrition and immunology: from the clinic to cellular biology and back again. Proc Nutr Soc. 1999;58(3):681–3. doi:https://doi.org/10.1017/s0029665199000890
- Sonnenschein C, Soto AM, Michaelson CL. Human serum albumin shares the properties of estrocolyone-I, the inhibitor of the proliferation of estrogen-target cells. J Steroid Biochem Mol Biol. 1996;59(2):147–54. doi:https://doi.org/10.1016/S0960-0760(96)00112-4
- Ligthart S, Marzi C, Aslibekyan S, Mendelson MM, Conneely KN, Tanaka T, Colicino E, Waite LL, Joehanes R, Guan W, et al. DNA methylation signatures of chronic low-grade inflammation are associated with complex diseases. Genome Biol. 2016;17(1):255. doi:https://doi.org/10.1186/s13059-016-1119-5
- Kubota T, Hiki N, Nunobe S, Kumagai K, Aikou S, Watanabe R, Sano T, Yamaguchi T. Significance of the inflammation-based Glasgow prognostic score for short- and long-term outcomes after curative resection of gastric cancer. J Gastrointest Surg. 2012;16(11):2037–44. doi:https://doi.org/10.1007/s11605-012-2036-x
- Hirashima K, Watanabe M, Shigaki H, Imamura Y, Ida S, Iwatsuki M, Ishimoto T, Iwagami S, Baba Y, Baba H, et al. Prognostic significance of the modified Glasgow prognostic score in elderly patients with gastric cancer. J Gastroenterol. 2014;49(6):1040–6. doi:https://doi.org/10.1007/s00535-013-0855-5
- Valenzuela-Landaeta K, Rojas P, Basfi-Fer K. [Nutritional assessment for cancer patient]. Nutr Hosp. 2012;27(2):516–23. doi:https://doi.org/10.1590/S0212-16112012000200025
- Hao X, Wei Y, Wei X, Zhou L, Wei Q, Zhang Y, Huang W, Feng R. Glasgow prognostic score is superior to other inflammation-based scores in predicting survival of diffuse large B cell lymphoma. Oncotarget. 2017;8(44):76740–8. doi:https://doi.org/10.18632/oncotarget.20832
- Wang Y, Yang L, Xia L, Chen Y. High C-reactive protein/albumin ratio predicts unfavorable distant metastasis-free survival in nasopharyngeal carcinoma: a propensity score-matched analysis. Cancer Manag Res. 2018;10:371–81. doi:https://doi.org/10.2147/CMAR.S155604
- Llop- Talaveron J, Badia-Tahull MB, Leiva-Badosa E. An inflammation-based prognostic score, the C-reactive protein/albumin ratio predicts the morbidity and mortality of patients on parenteral nutrition. Clin Nutr. 2018;37(5):1575–83. doi:https://doi.org/10.1016/j.clnu.2017.08.013
- Wu M-T, He S-Y, Chen S-L, Li L-F, He Z-Q, Zhu Y-Y, He X, Chen H. Clinical and prognostic implications of pretreatment albumin to C-reactive protein ratio in patients with hepatocellular carcinoma. BMC Cancer. 2019;19(1):538. doi:https://doi.org/10.1186/s12885-019-5747-5
- Fruchtenicht AVG, Poziomyck AK, Reis AMD, Galia CR, Kabke GB, Moreira LF. Inflammatory and nutritional statuses of patients submitted to resection of gastrointestinal tumors. Rev Col Bras Cir. 2018;45(2):e1614. doi:https://doi.org/10.1590/0100-6991e-20181614
- Quyen TC, Angkatavanich J, Thuan TV, Xuan VV, Tuyen LD, Tu DA. Nutrition assessment and its relationship with performance and glasgow prognostic scores in Vietnamese patients with oesophagal cancer. Asia Pac J Clin Nutr. 2017;26(1):49–58.
- Gao Y, Huang D. The value of the systematic inflammation‑based Glasgow Prognostic Score in patients with gastric cancer: a literature review. J Can Res Ther. 2014;10(4):799–804. doi:https://doi.org/10.4103/0973-1482.146054
- Elahi MM, McMillan DC, McArdle CS, Angerson WJ, Sattar N. Score based on hypoalbuminemia and elevated C-reactive protein predicts survival in patients with advanced gastrointestinal cancer. Nutr Cancer. 2004;48(2):171–3. doi:https://doi.org/10.1207/s15327914nc4802_6
- Murri AMA, Bartlett JMS, Canney PA, Doughty JC, Wilson C, McMillan DC. Evaluation of an inflammation-based prognostic score (GPS) in patients with metastatic breast cancer. Br J Cancer. 2006;94(2):227–30. doi:https://doi.org/10.1038/sj.bjc.6602922
- Alberici Pastore C, Paiva Orlandi S, González MC. The inflammatory-nutritional index; assessing nutritional status and prognosis in gastrointestinal and lung cancer patients. Nutr Hosp. 2014;29(3):629–34.
- Ranzani OT, Zampieri FG, Forte DN, Azevedo LC, Park M. C-reactive protein/albumin ratio predicts 90-day mortality of septic patients. PLoS One. 2013;8(3):e59321. doi:https://doi.org/10.1371/journal.pone.0059321
- Liu Z, Jin K, Guo M, Long J, Liu L, Liu C, Xu J, Ni Q, Luo G, Yu X. Prognostic value of the CRP/Alb ratio, a novel inflammation-based score in pancreatic cancer. Ann Surg Oncol. 2017;24(2):561–8. doi:https://doi.org/10.1245/s10434-016-5579-3
- Xu XL, Yu HQ, Hu W, Song Q, Mao WM. A novel inflammation-based prognostic score, the C-reactive protein/albumin ratio predicts the prognosis of patients with operable esophageal squamous cell carcinoma. PLoS One. 2015;10(9):e0138657. doi:https://doi.org/10.1371/journal.pone.0138657
- Yang J-R, Xu J-Y, Chen G-C, Yu N, Yang J, Zeng D-X, Gu M-J, Li D-P, Zhang Y-S, Qin L-Q. Post-diagnostic C-reactive protein and albumin predict survival in Chinese patients with non-small cell lung cancer: a prospective cohort study. Sci Rep. 2019;9(1):8143. doi:https://doi.org/10.1038/s41598-019-40627-1
- Wu J, Tan W, Chen L, Huang Z, Mai S. Clinicopathologic and prognostic significance of C-reactive protein/albumin ratio in patients with solid tumors: an updated systemic review and meta-analysis. Oncotarget. 2018;9(17):13934–47. doi:https://doi.org/10.18632/oncotarget.24172
- Poziomyck AK, Fruchtenicht AVG, Kabke GB, Volkweis BS, Antoniazzi JL, Moreira LF. Reliability of nutritional assessment in patients with gastrointestinal tumors. Rev Col Bras Cir. 2016;43(3):189–97. doi:https://doi.org/10.1590/0100-69912016003006
- Berger E, Delpierre C, Hosnijeh FS, Kelly-Irving M, Portengen L, Bergdahl IA, Johansson A-S, Krogh V, Palli D, Panico S, et al. Association between low-grade inflammation and breast cancer and B-cell myeloma and non-Hodgkin lymphoma: findings from two prospective cohorts. Sci Rep. 2018;8(1):10805. doi:https://doi.org/10.1038/s41598-018-29041-1
- Khan S, Shukla S, Sinha S, Meeran SM. Role of adipokines and cytokines in obesity-associated breast cancer: therapeutic targets. Cytokine Growth Factor Rev. 2013;24(6):503–13. doi:https://doi.org/10.1016/j.cytogfr.2013.10.001
- Iyengar NM, Hudis CA, Dannenberg AJ. Obesity and inflammation: new insights into breast cancer development and progression. Am Soc Clin Oncol Educ Book. 2013;33:46–51. doi:https://doi.org/10.1200/EdBook_AM.2013.33.46
- Dias JA, Fredrikson GN, Ericson U, Gullberg B, Hedblad B, Engström G, Borgquist S, Nilsson J, Wirfält E. Low-grade inflammation, oxidative stress and risk of invasive post-menopausal breast cancer - a nested case-control study from the Malmö diet and cancer cohort. PLoS One. 2016;11(7):e0158959. doi:https://doi.org/10.1371/journal.pone.0158959
- Ofunre E, Kenneth A, Osagie IJ. Assessment of some biomarkers of inflammation in breast cancer patients in Benin City. Niger J Surg Sci. 2017;27(2):33–6. doi:https://doi.org/10.4103/njss.njss_2_14